CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Open-market buy Director bought 4,716 shares at an average $1.74 ($8,209)
- 8-K Event Other events
- 4 Open-market buy Director bought 647 shares at an average $1.17 ($755)
- 4 Open-market buy Director bought 1,506 shares at an average $1.17 ($1,755)
- 4 Open-market buy Chairman and CEO bought 1,506 shares at an average $1.17 ($1,755)
- 4 Open-market buy Director bought 8,029 shares at an average $1.16 ($9,348)
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Open-market buy Director bought 713 shares at an average $1.28 ($914)
- 4 Open-market buy Director bought 1,426 shares at an average $1.28 ($1,827)
- 4 Open-market buy Chairman and CEO bought 1,426 shares at an average $1.28 ($1,827)
- 4 Open-market buy Director bought 7,107 shares at an average $1.28 ($9,106)
- 8-K Event Other events
- 4 Other acquisition Director acquired 446 shares (code L)
- 4 Other acquisition Director acquired 892 shares (code L)
- 4 Other acquisition Chairman and CEO acquired 892 shares (code L)
- 4 Other acquisition Director acquired 4,464 shares (code L)
- 4 Other acquisition Director acquired 402 shares (code L)
Page 7 of 52 · 1,039 filings